Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 312

1.

Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease.

Jensen-Urstad K, Svenungsson E, de Faire U, Silveira A, Witztum JL, Hamsten A, Frostegård J.

Lupus. 2002;11(11):744-52.

PMID:
12475005
[PubMed - indexed for MEDLINE]
2.

Risk factors for cardiovascular disease in systemic lupus erythematosus.

Svenungsson E, Jensen-Urstad K, Heimbürger M, Silveira A, Hamsten A, de Faire U, Witztum JL, Frostegård J.

Circulation. 2001 Oct 16;104(16):1887-93.

PMID:
11602489
[PubMed - indexed for MEDLINE]
Free Article
3.

Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus.

Leung WH, Wong KL, Lau CP, Wong CK, Liu HW.

Am J Med. 1990 Oct;89(4):411-9.

PMID:
2121029
[PubMed - indexed for MEDLINE]
4.

Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies.

Leszczyński P, Straburzyńska-Migaj E, Korczowska I, Łacki JK, Mackiewicz S.

Clin Rheumatol. 2003 Dec;22(6):405-8. Epub 2003 Oct 14.

PMID:
14677016
[PubMed - indexed for MEDLINE]
5.

[Heart valve involvement in systemic lupus erythematosus: an echocardiographic study].

Marcon C, Moro E, Sforza P, Piccoli G, Maresca MC, Adami A.

G Ital Cardiol. 1992 Nov;22(11):1301-8. Italian.

PMID:
1297616
[PubMed - indexed for MEDLINE]
6.

Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.

Svenungsson E, Cederholm A, Jensen-Urstad K, Fei GZ, de Faire U, Frostegård J.

Scand J Rheumatol. 2008 Sep-Oct;37(5):352-9. doi: 10.1080/03009740802007514.

PMID:
18666029
[PubMed - indexed for MEDLINE]
7.

Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease.

Hua X, Su J, Svenungsson E, Hurt-Camejo E, Jensen-Urstad K, Angelin B, Båvenholm P, Frostegård J.

Scand J Rheumatol. 2009 May-Jun;38(3):184-9. doi: 10.1080/03009740802541470.

PMID:
19165647
[PubMed - indexed for MEDLINE]
8.

Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.

Frostegård J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Hörkkö S, Witztum JL.

Arthritis Rheum. 2005 Jan;52(1):192-200.

PMID:
15641060
[PubMed - indexed for MEDLINE]
Free Article
9.

Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.

Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE.

Arthritis Rheum. 2006 Dec;54(12):3918-25.

PMID:
17133599
[PubMed - indexed for MEDLINE]
Free Article
10.

Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.

Bessant R, Duncan R, Ambler G, Swanton J, Isenberg DA, Gordon C, Rahman A.

Arthritis Rheum. 2006 Dec 15;55(6):892-9.

PMID:
17139666
[PubMed - indexed for MEDLINE]
Free Article
11.

Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus.

Tso TK, Huang WN.

Rheumatol Int. 2009 May;29(7):735-42. doi: 10.1007/s00296-008-0781-7. Epub 2008 Nov 27.

PMID:
19037607
[PubMed - indexed for MEDLINE]
12.

Cardiac abnormalities in patients with systemic lupus erythematosus.

Cujec B, Sibley J, Haga M.

Can J Cardiol. 1991 Oct;7(8):343-9.

PMID:
1742668
[PubMed - indexed for MEDLINE]
13.

Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus.

Cederholm A, Svenungsson E, Stengel D, Fei GZ, Pockley AG, Ninio E, Frostegård J.

Arthritis Rheum. 2004 Sep;50(9):2869-76.

PMID:
15457454
[PubMed - indexed for MEDLINE]
Free Article
14.

Autoimmunity, oxidized LDL and cardiovascular disease.

Frostegård J.

Autoimmun Rev. 2002 Aug;1(4):233-7. Review.

PMID:
12849001
[PubMed - indexed for MEDLINE]
15.

Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.

Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, Kuller LH.

Arthritis Rheum. 1999 Jan;42(1):51-60.

PMID:
9920014
[PubMed - indexed for MEDLINE]
Free Article
16.

Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.

Gabrielli F, Alcini E, Di Prima MA, Mazzacurati G, Masala C.

Int J Cardiol. 1995 Sep;51(2):117-26.

PMID:
8522406
[PubMed - indexed for MEDLINE]
17.

[Cardiac abnormalities in systemic lupus erythematosus and their association with antiphospholipid antibodies].

Laganà B.

Recenti Prog Med. 1993 Oct;84(10):662-72. Italian.

PMID:
8235032
[PubMed - indexed for MEDLINE]
18.

Disease chronicity and activity predict subclinical left ventricular systolic dysfunction in patients with systemic lupus erythematosus.

Yip GW, Shang Q, Tam LS, Zhang Q, Li EK, Fung JW, Yu CM.

Heart. 2009 Jun;95(12):980-7. doi: 10.1136/hrt.2008.153551. Epub 2009 Feb 23.

PMID:
19240052
[PubMed - indexed for MEDLINE]
19.

An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus.

Roldan CA, Shively BK, Crawford MH.

N Engl J Med. 1996 Nov 7;335(19):1424-30.

PMID:
8875919
[PubMed - indexed for MEDLINE]
Free Article
20.

The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement.

Amoroso A, Cacciapaglia F, De Castro S, Battagliese A, Coppolino G, Galluzzo S, Vadacca M, Afeltra A.

Clin Exp Rheumatol. 2006 May-Jun;24(3):287-94.

PMID:
16870096
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk